Insider Transactions in Q3 2018 at Pfizer Inc (PFE)
Insider Transaction List (Q3 2018)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 13
2018
|
Mikael Dolsten President R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
181,712
+30.45%
|
$4,724,512
$26.63 P/Share
|
|
Aug 13
2018
|
Laurie J Olson Executive Vice President |
SELL
Open market or private sale
|
Direct |
10,214
-12.32%
|
$418,774
$41.0 P/Share
|
|
Aug 03
2018
|
Alexander R Mackenzie Executive Vice President |
SELL
Open market or private sale
|
Direct |
25,642
-3.58%
|
$1,000,038
$39.53 P/Share
|
|
Aug 01
2018
|
Frank A Damelio Executive Vice President |
SELL
Open market or private sale
|
Direct |
150,484
-30.84%
|
$6,019,360
$40.0 P/Share
|
|
Aug 01
2018
|
Kirsten Lund Jurgensen Executive Vice President |
SELL
Open market or private sale
|
Direct |
20,942
-49.05%
|
$837,680
$40.05 P/Share
|
|
Aug 01
2018
|
Loretta V Cangialosi Sr. Vice President, Controller |
SELL
Open market or private sale
|
Direct |
26,814
-12.79%
|
$1,072,560
$40.16 P/Share
|
|
Aug 01
2018
|
Michael Goettler Group President |
SELL
Open market or private sale
|
Direct |
19,198
-19.24%
|
$748,722
$39.71 P/Share
|
|
Jul 20
2018
|
Sally Susman Executive Vice President |
SELL
Open market or private sale
|
Direct |
40,381
-1.64%
|
$1,494,097
$37.22 P/Share
|
|
Jul 16
2018
|
Ian C Read Executive Chairman |
SELL
Open market or private sale
|
Direct |
486,753
-2.15%
|
$18,009,861
$37.42 P/Share
|